Chapter I Oxidative Stress and Fatty Acids in Neuropsychiatric Disorders:How Are They Connected? -- Chapter II Diet in Schizophrenia: an Overview -- SECTION I: OXIDATIVE STRESS -- Chapter III Oxidative Stress in Schizophrenia -- Chapter IV Antipsychotic Agents and Oxidative Stress -- Chapter V Oxidative Stress in Parkinson's Disease -- Chapter VI Oxidative Stress and Altered Sphingolipid Metabolism in Alzheimer's Disease -- SECTION II: FATTY ACID DEFICITS -- Chapter VII Membrane Fatty Acid Deficit in Schizophrenia and Mood Disorders -- Chapter VIII Essential Fatty Acids and Neurodevelopmental Disorders -- SECTION III: THERAPEUTIC PROSPECTS -- Chapter IX Fatty Acids and Oxidative Stress in Neurodevelopmental Disorders of Childhood: Treatment Implications -- Chapter X Essential Fatty Acid Supplementation in Schizophrenia and Mood Disorders -- Chapter XI Bioactive Lipids, Niacin Sensitivity and Cognition in Schizophrenia -- Chapter XII Schizophrenia, CAD and Omega-3 Fatty Acids -- Chapter XIII Can Augmentation Enhance Antipsychotic Treatment Response in Schizophrenia?Omega-3 Fatty Acid and Antioxidant Supplementation -- SECTION IV: THEORETICAL AND METHODOLOGICAL FRONTIERS -- Chapter XIV Apolipoprotein D and Arachidonic Acid Interactions in the Treatment and Pathology of Schizophrenia -- Chapter XV Long-Chain Polyunsaturated Fatty Acids and Perinatal Origins of Schizophrenia -- Chapter XVI Unraveling Complexity by Integrative Biochemical Inverstigation.